Mavacamten will reduce the extent or influence of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may possibly minimize systemic exposures of ethinyl estradiol and progestin, which can result in contraceptive failure or a rise in https://alexanderf318ego1.wikiexpression.com/user